Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomized, phase 3 study

L. Kappos, A. Bar-Or, B.A.C. Cree, R.J. Fox, C. Giovannoni, P. Vermersch, D.L. Arnold, S. Arnould, T. Schertz, C. Wolf, E. Walstrom, F. Dahlke, L. H. Visser

Research output: Contribution to journalArticleAcademic

Original languageAmerican English
Pages (from-to)1263-1273
Number of pages11
JournalThe Lancet (London)
Volume391
Publication statusPublished - 1 Jan 2018

Cite this